Comprehensive Frailty Assessment

Status Completed

Clinical Trial Summary

The purpose of this research study is to describe a patients' fitness before and after treatment (whether that treatment be chemotherapy or a transplant). Fitness is a way of measuring a patient's current quality of health. With surveys, questionnaires and blood tests, we hope to create a tool that will give a good picture of patients' ability to tolerate treatment. In the future, we hope to devise the best treatment for a patient based on their "fitness".

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02033928
Study type	Observational
Source	Ohio State University Comprehensive Cancer Center
Contact
Status	Completed
Phase	N/A
Start date	April 2014
Completion date	August 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03483194` - Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)	Phase 2/Phase 3
Recruiting	`NCT03735992` - Mind-body Medicine for Patients With Malignant Hematological Diseases	N/A
Recruiting	`NCT04959175` - Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies	Phase 1/Phase 2
Withdrawn	`NCT04275154` - Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy
Terminated	`NCT00957580` - Trial of Pimasertib in Hematological Malignancies	Phase 2
Completed	`NCT00997386` - Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States	Phase 2
Completed	`NCT00389428` - Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.	Phase 1
Completed	`NCT02193880` - Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)	N/A
Recruiting	`NCT00071045` - Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Not yet recruiting	`NCT05054231` - Immunological Profile for Patients Treated With CAR-T Cells	N/A
Completed	`NCT02650791` - Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study	Phase 3
Completed	`NCT01362179` - National Marrow Donor Program Long-Term Donor Follow-Up
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Terminated	`NCT03648372` - A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System	Phase 1/Phase 2
Recruiting	`NCT03320915` - Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT	Phase 2
Recruiting	`NCT06422533` - Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients	N/A
Terminated	`NCT02895529` - A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy	Phase 4
Active, not recruiting	`NCT03680092` - Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation	Phase 2
Recruiting	`NCT03083327` - Prophylactic Early PN in HPT/BMT	N/A
Recruiting	`NCT03743480` - Early Palliative Care and Hematological Cancer Patients	N/A